Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 668

1.

Magnetic Resonance-Guided Prostate Ablation.

Woodrum DA, Kawashima A, Gorny KR, Mynderse LA.

Semin Intervent Radiol. 2019 Dec;36(5):351-366. doi: 10.1055/s-0039-1697001. Epub 2019 Dec 2. Review.

PMID:
31798208
2.

Stereoselective Organic Reactions in Heterogeneous Semiconductor Photocatalysis.

Kohtani S, Kawashima A, Miyabe H.

Front Chem. 2019 Sep 18;7:630. doi: 10.3389/fchem.2019.00630. eCollection 2019. Review.

3.

The Effects of Mold-Fermented Cheese on Brain-Derived Neurotrophic Factor in Community-Dwelling Older Japanese Women With Mild Cognitive Impairment: A Randomized, Controlled, Crossover Trial.

Suzuki T, Kojima N, Osuka Y, Tokui Y, Takasugi S, Kawashima A, Yamaji T, Hosoi E, Won CW, Kim H.

J Am Med Dir Assoc. 2019 Dec;20(12):1509-1514.e2. doi: 10.1016/j.jamda.2019.06.023. Epub 2019 Sep 24.

PMID:
31562049
4.

Amplicon Sequencing-Based Noninvasive Fetal Genotyping for RHD-Positive D Antigen-Negative Alleles.

Takahashi K, Migita O, Sasaki A, Nasu M, Kawashima A, Sekizawa A, Sato T, Ito Y, Sago H, Okamoto A, Nakabayashi K, Hata K.

Clin Chem. 2019 Oct;65(10):1307-1316. doi: 10.1373/clinchem.2019.307074. Epub 2019 Sep 5.

PMID:
31488553
5.

Importance of Multiparametric Evaluation of Immune-Related T-Cell Markers in Renal-Cell Carcinoma.

Kawashima A, Uemura M, Nonomura N.

Clin Genitourin Cancer. 2019 Dec;17(6):e1147-e1152. doi: 10.1016/j.clgc.2019.07.021. Epub 2019 Aug 5. Review.

PMID:
31473121
6.

Tandem Alkylation-Second-Order Asymmetric Transformation Protocol for the Preparation of Phenylalanine-Type Tailor-Made α-Amino Acids.

Takeda R, Kawashima A, Yamamoto J, Sato T, Moriwaki H, Izawa K, Abe H, Soloshonok VA.

ACS Omega. 2018 Aug 22;3(8):9729-9737. doi: 10.1021/acsomega.8b01424. eCollection 2018 Aug 31.

7.

A three-gene DNA methylation biomarker accurately classifies early stage prostate cancer.

Patel PG, Wessel T, Kawashima A, Okello JBA, Jamaspishvili T, Guérard KP, Lee L, Lee AY, How NE, Dion D, Scarlata E, Jackson CL, Boursalie S, Sack T, Dunn R, Moussa M, Mackie/ K, Ellis A, Marra E, Chin J, Siddiqui K, Hetou K, Pickard LA, Arthur-Hayward V, Bauman G, Chevalier S, Brimo F, Boutros PC, Lapointe PhD J, Bartlett JMS, Gooding RJ, Berman DM.

Prostate. 2019 Oct;79(14):1705-1714. doi: 10.1002/pros.23895. Epub 2019 Aug 21.

PMID:
31433512
8.

PHLPP1 counter-regulates STAT1-mediated inflammatory signaling.

Cohen Katsenelson K, Stender JD, Kawashima AT, Lordén G, Uchiyama S, Nizet V, Glass CK, Newton AC.

Elife. 2019 Aug 13;8. pii: e48609. doi: 10.7554/eLife.48609.

9.

MRI - ultrasound fusion guided biopsy of the prostate: lesion volume as a predictor of cancer in patients with repeat biopsies.

Blaine SA, Abdul-Muhsin HM, Jakob NJ, Andrews PE, Ferrigni RG, Cha SS, Golshani A, Silva AC, Kawashima A, Humphreys MR.

Indian J Urol. 2019 Jul-Sep;35(3):208-212. doi: 10.4103/iju.IJU_49_19.

10.

Infantile Aspergillus fumigatus ventriculitis successfully treated with monitoring of plasma and cerebrospinal fluid voriconazole concentration level.

Furudate A, Hirose S, Abe K, Kawashima A, Hashimoto K, Yamazaki S, Kamei K, Ishiwada N, Hamada H, Sato M.

J Infect Chemother. 2020 Jan;26(1):132-135. doi: 10.1016/j.jiac.2019.06.011. Epub 2019 Jul 23.

PMID:
31350185
11.

Peri-operative monocyte count is a marker of poor prognosis in gastric cancer: increased monocytes are a characteristic of myeloid-derived suppressor cells.

Urakawa S, Yamasaki M, Goto K, Haruna M, Hirata M, Morimoto-Okazawa A, Kawashima A, Iwahori K, Makino T, Kurokawa Y, Yamada T, Mori M, Doki Y, Wada H.

Cancer Immunol Immunother. 2019 Aug;68(8):1341-1350. doi: 10.1007/s00262-019-02366-0. Epub 2019 Jul 19.

PMID:
31324947
12.

Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism.

Kawashima A, Sone M, Inagaki N, Takeda Y, Itoh H, Kurihara I, Umakoshi H, Ichijo T, Katabami T, Wada N, Ogawa Y, Kawashima J, Fujita M, Miyauchi S, Okamura S, Fukuoka T, Yanase T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Kai T, Suzuki T, Naruse M.

Eur J Endocrinol. 2019 Jul 1. pii: EJE-19-0047.R2. doi: 10.1530/EJE-19-0047. [Epub ahead of print]

PMID:
31319380
13.

RNA sequencing analysis revealed the induction of CCL3 expression in human intracranial aneurysms.

Aoki T, Koseki H, Miyata H, Itoh M, Kawaji H, Takizawa K, Kawashima A, Ujiie H, Higa T, Minamimura K, Kimura T, Kasuya H, Nozaki K, Morita A, Sano H, Narumiya S.

Sci Rep. 2019 Jul 17;9(1):10387. doi: 10.1038/s41598-019-46886-2.

14.

Radon Therapy for Autoimmune Diseases Pemphigus and Diabetes: 2 Case Reports.

Kojima S, Cuttler JM, Shimura N, Koga H, Murata A, Kawashima A.

Dose Response. 2019 May 19;17(2):1559325819850984. doi: 10.1177/1559325819850984. eCollection 2019 Apr-Jun.

15.

Hypothetical Factors that May Affect the "Reported" Prevalence of Mondor's Disease.

Teshigawara M, Kawashima A, Wada M.

Intern Med. 2019 Sep 1;58(17):2593. doi: 10.2169/internalmedicine.1845-18. Epub 2019 Jun 7. No abstract available.

16.

Elderly patients with lower-jaw mobility require careful food texture modification: A cohort study.

Wada M, Hanamoto A, Kawashima A.

J Gen Fam Med. 2019 Feb 27;20(3):93-100. doi: 10.1002/jgf2.240. eCollection 2019 May.

17.

Genotype-Phenotype Correlation in Long-Term Cohort of Japanese Patients with Moyamoya Disease.

Nomura S, Yamaguchi K, Akagawa H, Kawashima A, Moteki Y, Ishikawa T, Aihara Y, Saito T, Okada Y, Kawamata T.

Cerebrovasc Dis. 2019;47(3-4):105-111. doi: 10.1159/000499699. Epub 2019 Apr 4.

18.

EFCAB2 is a novel calcium-binding protein in mouse testis and sperm.

Shawki HH, Ishikawa-Yamauchi Y, Kawashima A, Katoh Y, Matsuda M, Al-Soudy AS, Minisy FM, Kuno A, Gulibaikelamu X, Hirokawa T, Takahashi S, Oishi H.

PLoS One. 2019 Apr 1;14(4):e0214687. doi: 10.1371/journal.pone.0214687. eCollection 2019.

19.

Rare and Low-Frequency Variants in RNF213 Confer Susceptibility to Moyamoya Syndrome Associated with Hyperthyroidism.

Nomura S, Akagawa H, Yamaguchi K, Ishikawa T, Kawashima A, Kasuya H, Mukawa M, Nariai T, Maehara T, Okada Y, Kawamata T.

World Neurosurg. 2019 Jul;127:e460-e466. doi: 10.1016/j.wneu.2019.03.172. Epub 2019 Mar 25.

PMID:
30922903
20.

Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma.

Hayashi Y, Fujita K, Matsuzaki K, Matsushita M, Kawamura N, Koh Y, Nakano K, Wang C, Ishizuya Y, Yamamoto Y, Jingushi K, Kato T, Kawashima A, Ujike T, Nagahara A, Uemura M, Imamura R, Takao T, Takada S, Netto GJ, Nonomura N.

Cancer Sci. 2019 May;110(5):1771-1779. doi: 10.1111/cas.14000. Epub 2019 Apr 7.

21.

Use of kZ -space for high through-plane resolution in multislice MRI: Application to prostate.

Kargar S, Borisch EA, Froemming AT, Grimm RC, Kawashima A, King BF, Stinson EG, Riederer SJ.

Magn Reson Med. 2019 Jun;81(6):3691-3704. doi: 10.1002/mrm.27691. Epub 2019 Mar 7.

PMID:
30844092
22.

Usefulness of color Doppler mode for fetal cardiac ultrasound screening in the second trimester: a study at a single perinatal center.

Takita H, Matsuoka R, Tokunaka M, Goto M, Arakaki T, Kawashima A, Oba T, Nakamura M, Sekizawa A.

J Matern Fetal Neonatal Med. 2019 Mar 5:1-4. doi: 10.1080/14767058.2019.1583731. [Epub ahead of print]

PMID:
30835602
23.

Inhibitory effects of methimazole and propylthiouracil on iodotyrosine deiodinase 1 in thyrocytes.

Yoshihara A, Luo Y, Ishido Y, Usukura K, Oda K, Sue M, Kawashima A, Hiroi N, Suzuki K.

Endocr J. 2019 Apr 25;66(4):349-357. doi: 10.1507/endocrj.EJ18-0380. Epub 2019 Feb 27.

24.

Multiple unilateral subcapsular cortical hemorrhagic cystic disease of the kidney: CT and MRI findings and clinical characteristic.

Yoshida K, Takahashi N, King BF, Kawashima A, Harris PC, Cornell LD, Cornec-Le Gall E, Inoue D, Mizushima I, Kawano M, Thervet E, de Cotret PR, Torres VE.

Eur Radiol. 2019 Sep;29(9):4843-4850. doi: 10.1007/s00330-019-06057-3. Epub 2019 Feb 26.

25.

Peripheral T cell cytotoxicity predicts T cell function in the tumor microenvironment.

Iwahori K, Shintani Y, Funaki S, Yamamoto Y, Matsumoto M, Yoshida T, Morimoto-Okazawa A, Kawashima A, Sato E, Gottschalk S, Okumura M, Kumanogoh A, Wada H.

Sci Rep. 2019 Feb 22;9(1):2636. doi: 10.1038/s41598-019-39345-5.

26.

Clinical factors influencing the development of extracranial-intracranial bypass graft for steno-occlusive cerebrovascular disease.

Nomura S, Yamaguchi K, Ishikawa T, Kawashima A, Okada Y, Kawamata T.

Neurosurg Focus. 2019 Feb 1;46(2):E5. doi: 10.3171/2018.11.FOCUS18500.

PMID:
30717071
27.

Safety and Image Quality of 1.5-T Endorectal Coil Multiparametric MRI of the Prostate or Prostatectomy Fossa for Patients With Pacemaker or Implantable Cardioverter-Defibrillator.

Tanaka T, Froemming AT, Panda A, Edmonson HA, Pooley RA, Carter RE, King BF, Kawashima A.

AJR Am J Roentgenol. 2019 Apr;212(4):815-822. doi: 10.2214/AJR.18.20266. Epub 2019 Jan 30.

PMID:
30699008
28.

A 3-year follow-up study of radiotherapy using computed tomography-based image-guided brachytherapy for cervical cancer.

Kawashima A, Isohashi F, Mabuchi S, Sawada K, Ueda Y, Kobayashi E, Matsumoto Y, Otani K, Tamari K, Seo Y, Suzuki O, Sumida I, Tomimatsu T, Kimura T, Ogawa K.

J Radiat Res. 2019 Mar 1;60(2):264-269. doi: 10.1093/jrr/rry104.

29.

Real-world safety and efficacy of sofosbuvir and ledipasvir for elderly patients.

Tamai H, Shingaki N, Ida Y, Shimizu R, Maeshima S, Okamura J, Kawashima A, Nakao T, Hara T, Matsutani H, Nishikawa I, Higashi K.

JGH Open. 2018 Sep 19;2(6):300-306. doi: 10.1002/jgh3.12088. eCollection 2018 Dec.

30.

Correction to: Efficacy of superficial temporal artery-middle cerebral artery double bypass in patients with hemorrhagic moyamoya disease: surgical effects for operated hemispheric sides.

Ishiguro T, Okada Y, Ishikawa T, Yamaguchi K, Kawashima A, Kawamata T.

Neurosurg Rev. 2019 Jun;42(2):569. doi: 10.1007/s10143-018-01073-1.

PMID:
30610498
31.

Phenotypic Analysis of Tumor Tissue-Infiltrating Lymphocytes in Tumor Microenvironment of Bladder Cancer and Upper Urinary Tract Carcinoma.

Kawashima A, Kanazawa T, Jingushi K, Kato T, Ujike T, Nagahara A, Fujita K, Morimoto-Okazawa A, Iwahori K, Uemura M, Imamura R, Wada H, Nonomura N.

Clin Genitourin Cancer. 2019 Apr;17(2):114-124. doi: 10.1016/j.clgc.2018.11.004. Epub 2018 Nov 17.

PMID:
30555025
32.

Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma.

Yamamoto Y, Uemura M, Fujita M, Maejima K, Koh Y, Matsushita M, Nakano K, Hayashi Y, Wang C, Ishizuya Y, Kinouchi T, Hayashi T, Matsuzaki K, Jingushi K, Kato T, Kawashima A, Ujike T, Nagahara A, Fujita K, Imamura R, Nakagawa H, Nonomura N.

Cancer Sci. 2019 Feb;110(2):617-628. doi: 10.1111/cas.13906. Epub 2019 Jan 25.

33.

Complications of Intravesical BCG Immunotherapy for Bladder Cancer.

Green DB, Kawashima A, Menias CO, Tanaka T, Redelman-Sidi G, Bhalla S, Shah R, King BF.

Radiographics. 2019 Jan-Feb;39(1):80-94. doi: 10.1148/rg.2019180014. Epub 2018 Dec 7.

PMID:
30526332
34.

Efficacy of superficial temporal artery-middle cerebral artery double bypass in patients with hemorrhagic moyamoya disease: surgical effects for operated hemispheric sides.

Ishiguro T, Okada Y, Ishikawa T, Yamaguchi K, Kawashima A, Kawamata T.

Neurosurg Rev. 2019 Jun;42(2):559-568. doi: 10.1007/s10143-018-01059-z. Epub 2018 Dec 3. Erratum in: Neurosurg Rev. 2019 Jan 4;:.

PMID:
30511308
35.

Leukocyte‑associated immunoglobulin‑like receptor 1 promotes tumorigenesis in RCC.

Jingushi K, Uemura M, Nakano K, Hayashi Y, Wang C, Ishizuya Y, Yamamoto Y, Hayashi T, Kinouchi T, Matsuzaki K, Kato T, Kawashima A, Ujike T, Nagahara A, Fujita K, Ueda K, Tsujikawa K, Nonomura N.

Oncol Rep. 2019 Feb;41(2):1293-1303. doi: 10.3892/or.2018.6875. Epub 2018 Nov 20.

PMID:
30483814
36.

Recurrent biliary dissemination of colon cancer liver metastasis: a case report.

Onishi I, Kayahara M, Takei R, Makita N, Munemoto M, Yagi Y, Kawashima A.

J Med Case Rep. 2018 Oct 27;12(1):314. doi: 10.1186/s13256-018-1858-x.

37.

Publisher Correction: Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration.

Nakabayashi M, Kawashima A, Yasuhara R, Hayakawa Y, Miyamoto S, Iizuka C, Sekizawa A.

Sci Rep. 2018 Oct 23;8(1):15883. doi: 10.1038/s41598-018-34168-2.

38.

Chiral α-hydroxy acid-coadsorbed TiO2 photocatalysts for asymmetric induction in hydrogenation of aromatic ketones.

Kohtani S, Kawashima A, Masuda F, Sumi M, Kitagawa Y, Yoshioka E, Hasegawa Y, Miyabe H.

Chem Commun (Camb). 2018 Nov 6;54(89):12610-12613. doi: 10.1039/c8cc07295g.

PMID:
30346464
39.

Targeted Prostate Biopsy and MR-Guided Therapy for Prostate Cancer.

Woodrum DA, Kawashima A, Gorny KR, Mynderse LA.

Adv Exp Med Biol. 2018;1096:159-184. doi: 10.1007/978-3-319-99286-0_9. Review.

PMID:
30324353
40.

Clinicopathological features of immunoglobulin G4-related pleural lesions and diagnostic utility of pleural effusion cytology.

Kasashima S, Kawashima A, Ozaki S, Kita T, Araya T, Ohta Y, Suzuki M.

Cytopathology. 2019 May;30(3):285-294. doi: 10.1111/cyt.12641. Epub 2018 Nov 8.

PMID:
30290034
41.

A case of chronic pancreatitis exacerbation associated with pancreatic arteriovenous malformation: a case report and literature review.

Seike T, Komura T, Shimizu Y, Omura H, Kumai T, Kagaya T, Ohta H, Kawashima A, Harada K, Kaneko S, Unoura M.

Clin J Gastroenterol. 2019 Apr;12(2):135-141. doi: 10.1007/s12328-018-0901-1. Epub 2018 Sep 4. Review.

PMID:
30182162
42.

Increased Tim-3+ T cells in PBMCs during nivolumab therapy correlate with responses and prognosis of advanced esophageal squamous cell carcinoma patients.

Kato R, Yamasaki M, Urakawa S, Nishida K, Makino T, Morimoto-Okazawa A, Kawashima A, Iwahori K, Suzuki S, Ueda R, Mori M, Satoh T, Doki Y, Wada H.

Cancer Immunol Immunother. 2018 Nov;67(11):1673-1683. doi: 10.1007/s00262-018-2225-x. Epub 2018 Aug 20.

PMID:
30128737
43.

Results of weekday-on and weekend-off administration schedule of sunitinib therapy for advanced renal cell carcinoma.

Kawashima A, Uemura M, Kato T, Ujike T, Nagahara A, Fujita K, Imamura R, Yamanaka Y, Tomiyama E, Tanigawa G, Miyagawa Y, Yoshioka T, Miyake O, Nonomura N.

Int J Clin Oncol. 2019 Jan;24(1):78-86. doi: 10.1007/s10147-018-1332-1. Epub 2018 Aug 9.

44.

Predicting the Occurrence of Hemorrhagic Cerebral Hyperperfusion Syndrome Using Regional Cerebral Blood Flow After Direct Bypass Surgery in Patients with Moyamoya Disease.

Ishikawa T, Yamaguchi K, Kawashima A, Funatsu T, Eguchi S, Matsuoka G, Nomura S, Kawamata T.

World Neurosurg. 2018 Nov;119:e750-e756. doi: 10.1016/j.wneu.2018.07.258. Epub 2018 Aug 6.

PMID:
30092464
45.

STAT3 expression is a prognostic marker in upper urinary tract urothelial carcinoma.

Matsuzaki K, Fujita K, Hayashi Y, Matsushita M, Nojima S, Jingushi K, Kato T, Kawashima A, Ujike T, Nagahara A, Uemura M, Imamura R, Yamaguchi S, Fushimi H, Miyamoto H, Morii E, Nonomura N.

PLoS One. 2018 Aug 9;13(8):e0201256. doi: 10.1371/journal.pone.0201256. eCollection 2018.

46.

IgG4-Related Pleuritis With No Other Organ Involvement.

Kita T, Araya T, Ichikawa Y, Terada N, Kawashima A, Kasashima S, Kasahara K.

Am J Med Sci. 2018 Nov;356(5):487-491. doi: 10.1016/j.amjms.2018.05.004. Epub 2018 May 9. Review.

PMID:
30055756
47.

Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration.

Nakabayashi M, Kawashima A, Yasuhara R, Hayakawa Y, Miyamoto S, Iizuka C, Sekizawa A.

Sci Rep. 2018 Jul 25;8(1):11205. doi: 10.1038/s41598-018-29381-y. Erratum in: Sci Rep. 2018 Oct 23;8(1):15883.

48.

Urologic tumor imaging.

Hartman RP, Kawashima A.

Eur J Radiol. 2018 Aug;105:239. doi: 10.1016/j.ejrad.2018.06.015. Epub 2018 Jun 21. No abstract available.

PMID:
30017286
49.

Letter to the Editor. Influence of rare RNF213 variants other than p.R4810K on the clinical outcomes of moyamoya disease.

Nomura S, Kawashima A, Akagawa H, Kawamata T.

J Neurosurg. 2018 Aug;129(2):563-565. doi: 10.3171/2018.1.JNS173211. Epub 2018 Jun 1. No abstract available.

PMID:
29999444
50.

Factors of Delayed Hyperperfusion and the Importance of Repeated Cerebral Blood Flow Evaluation for Hyperperfusion After Direct Bypass for Moyamoya Disease.

Nomura S, Yamaguchi K, Ishikawa T, Kawashima A, Okada Y, Kawamata T.

World Neurosurg. 2018 Oct;118:e468-e472. doi: 10.1016/j.wneu.2018.06.218. Epub 2018 Jul 7.

PMID:
29990604

Supplemental Content

Loading ...
Support Center